Mumbai-headquartered diagnostic services provider Metropolis Healthcare is eyeing 60 per cent of its revenues from the business-to-consumer (B2C) segment in the next two-three years. The company’s current share in the segment is 52 per cent. As Metropolis focuses on aggressive network expansion, it has been growing its B2C segment. This includes both the prescription-led… Continue reading Metropolis Healthcare eyes 60% revenue from B2C business in next 2-3 years